International Caffeine Study for Preterm Infants Launched

Researchers have initiated a massive trial to determine the safest and most effective caffeine dosages for premature babies.

Updated on Oct. 14, 2026 in Babies

Isometric editorial illustration showing a stylized, geometric medical apparatus, representing international clinical trial research on neonatal care. — Researchers have launched the BabyCCINO study, an international trial involving 4,000 preterm infants to determine optimal caffeine dosage for neonatal development. AI Illustration. Upload story photo >

Live Poll

Do you believe clinical trials involving infant medical treatments are essential for improving long-term care?

The new BabyCCINO study aims to standardize caffeine treatments for preterm infants across three countries. The trial will enroll 4,000 babies to evaluate how different caffeine dosing regimens impact long-term growth and development.

Why it matters

Current medical practices lack definitive data on the optimal caffeine dose to support breathing and brain development in preterm infants. This study aims to fill that knowledge gap to improve long-term health outcomes for vulnerable newborns.

The study compares three distinct caffeine dosing regimens to identify the most effective protocol for preterm babies. Researchers will conduct follow-up assessments on participant development two to three years after their discharge from the hospital.

The players

Mercy Hospital for Women

A specialized medical facility based in Melbourne, Australia, currently serving as a primary site for the international clinical trial.

The details

Caffeine is used in neonatal intensive care to stimulate the brains of preterm infants, which helps regulate their breathing. This trial systematically tests three different dosing levels across hospitals in Australia, New Zealand, and the United Kingdom. Researchers will track health outcomes throughout the hospital stay and perform long-term growth assessments to determine which dose provides the best developmental results.

The BabyCCINO study is currently launching at Mercy Hospital for Women.
Researchers will assess long-term infant development two to three years after hospital discharge.

The Home Front

The study represents a significant effort to standardize critical neonatal care protocols on a global scale. It marks a shift toward larger, multi-national trials to replace the fragmented dosing practices currently found in intensive care units.

Families with preterm infants currently in neonatal care should speak with their attending neonatologist about the hospital's specific caffeine protocols. It is helpful to keep a detailed medical record of all interventions and medications administered to your child during their NICU stay.

The takeaway

This trial is the largest of its kind and is expected to set new international standards for infant respiratory support. Parents should keep the results of their infant's hospital care and developmental follow-ups organized in a dedicated medical file for future consultations.